Early research (Phase 1)Ended earlyNCT04638634
What this trial is testing
Pharmacokinetics, Safety, and Tolerability of CSL760, an Intravenous Anti-SARS-CoV-2 Hyperimmune Globulin, in Healthy Adult Subjects
Who this might be right for
Coronavirus Disease 2019 (COVID-19)
CSL Behring 12